LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.81 | 84.90 | 1801 | 1769 | 1.0178 | 1.0081 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.81 | 84.90 | 1755 | 1769 | 0.9918 | 0.9963 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.81 | 84.90 | 1868 | 1769 | 1.0557 | 1.0249 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.81 | 84.90 | 23 | 1769 | 0.0130 | -0.2577 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.81 | 84.90 | 1567 | 1769 | 0.8856 | 0.9453 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.81 | 84.90 | 15 | 1769 | 0.0085 | -0.3267 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.81 | 84.90 | 1692 | 1769 | 0.9562 | 0.9797 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.51 | 84.90 | 1869 | 1923 | 0.9718 | 0.9874 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.51 | 84.90 | 1914 | 1923 | 0.9952 | 0.9979 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.51 | 84.90 | 1951 | 1923 | 1.0145 | 1.0064 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.51 | 84.90 | 2034 | 1923 | 1.0576 | 1.0250 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.51 | 84.90 | 35 | 1923 | 0.0182 | -0.1787 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.51 | 84.90 | 1675 | 1923 | 0.8710 | 0.9396 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.51 | 84.90 | 22 | 1923 | 0.0114 | -0.2592 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.51 | 84.90 | 1817 | 1923 | 0.9448 | 0.9749 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.21 | 84.90 | 2022 | 2091 | 0.9668 | 0.9854 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.21 | 84.90 | 2054 | 2091 | 0.9821 | 0.9922 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.21 | 84.90 | 2102 | 2091 | 1.0050 | 1.0022 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.21 | 84.90 | 2177 | 2091 | 1.0409 | 1.0174 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.21 | 84.90 | 48 | 2091 | 0.0230 | -0.1161 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.21 | 84.90 | 1823 | 2091 | 0.8716 | 0.9414 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.21 | 84.90 | 35 | 2091 | 0.0167 | -0.1744 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.21 | 84.90 | 1964 | 2091 | 0.9390 | 0.9730 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 29.92 | 84.90 | 2162 | 2237 | 0.9662 | 0.9855 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 29.92 | 84.90 | 2197 | 2237 | 0.9818 | 0.9922 | MN20160318_Q02 | D03 |